Free Trial
→ 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (From WealthPress) (Ad) Free TBPH Stock Alerts

Theravance Biopharma (TBPH) SEC Filings & 10K Form

Theravance Biopharma logo
$9.31 -0.35 (-3.62%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$9.31 0.00 (0.00%)
As of 02/21/2025 04:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Theravance Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
01/23/2025
5:05 PM		Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:04 PM		Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:06 PM		Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:08 PM		Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:09 PM		Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:10 PM		Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:08 PM		Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:53 AM		Madison Avenue Partners, LP (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
11/14/2024
5:06 AM		Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
7:42 PM		Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
2:33 PM		Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
1:10 PM		Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/24/2024
3:44 PM		BlackRock, Inc. (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
09/23/2024
5:05 AM		Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
5:02 AM		Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:42 PM		BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
08/22/2024
7:03 PM		Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:05 PM		Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:06 PM		Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:07 PM		Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:09 PM		Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
5:02 PM		Samaha Eli (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
5:05 PM		Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:57 PM		Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2024
5:15 PM		Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:02 PM		Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:04 PM		Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:06 PM		Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:08 PM		Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:10 PM		Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:01 PM		Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
5:26 AM		Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
5:01 PM		Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:02 PM		BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:04 PM		Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:06 PM		GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:09 PM		MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:10 PM		O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:12 PM		PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:15 PM		Theravance Biopharma (Filer)
Form DEF 14A
04/04/2024
5:09 PM		Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
9/9 on TSLA from June to January (Ad)

Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!

Tap here to catch the TGT case study and learn more
04/04/2024
5:11 PM		Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:13 PM		Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:15 PM		Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:17 PM		Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:06 PM		Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
8:01 AM		Theravance Biopharma (Subject)
Weiss Asset Management LP (Filed by)
Form SC 13D/A
02/22/2024
7:04 PM		Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:06 PM		GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:08 PM		Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:10 PM		Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:11 PM		Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:14 PM		Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:TBPH) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
BITCOIN
Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....
Awesomely, LLC | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...
Colonial Metals | Sponsored
Three new patents reveal Elon and Trump’s secret “Project America”
Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...
Timothy Sykes | Sponsored